Tutorials
Cabaletta Bio Inc logo

Cabaletta Bio Inc

$ 1.53 +0.08 (+5.52%) 08:09 PM EST
P/E:
At Loss
P/B:
0.42
Market Cap:
$ 44.34M
Enterprise V:
$ -64.88M
Volume:
292.00K
Avg Vol (2M):
259.85K
Volume:
292.00K
Market Cap $:
44.34M
PE Ratio:
At Loss
Avg Vol (2-Month):
259.85K
Enterprise Value $:
-64.88M
PB Ratio:
0.42
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Cabaletta Bio Inc
NAICS : 325412 SIC : 2834
2929 Arch Street, Suite 600, Philadelphia, PA, USA, 19104
Description
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAAR, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CAAR T cell product candidate was designed based on the clinically validated and commercially approved Chimeric Antigen Receptor, or CAR, T cell technology that is marketed for the treatment of B cell cancers.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.94
Interest Coverage No Debt
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -60.7
3-Year EPS without NRI Growth Rate 18.8
3-Year FCF Growth Rate -62.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 76.09
9-Day RSI 66.41
14-Day RSI 61.09
6-1 Month Momentum % -56.11
12-1 Month Momentum % -82.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.07
Quick Ratio 16.07
Cash Ratio 15.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.9
Name Current Vs Industry Vs History
ROE % -45.37
ROA % -42.93
ROIC % -1468.15
ROC (Joel Greenblatt) % -3565.78
ROCE % -45.43

Financials (Next Earnings Date:2022-11-01 Est.)

CABA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CABA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.84
Beta 0
Volatility % 95.13
14-Day RSI 61.09
14-Day ATR ($) 0.139133
20-Day SMA ($) 1.328
12-1 Month Momentum % -82.5
52-Week Range ($) 0.9 - 14.9499
Shares Outstanding (Mil) 28.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cabaletta Bio Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More